|
|
||||||||
1 The John B. Pierce Laboratory and Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut 06519; and 2 Women and Infants Hospital, Brown University School of Medicine, Providence, Rhode Island 02905
To test the hypothesis that progestin-mediated increases in resting core temperature and the core temperature threshold for sweating onset are counteracted by estrogen, we studied eight women (24 ± 2 yr) at 27°C rest, during 20 min of passive heating (35°C), and during 40 min of exercise at 35°C. Subjects were tested four times, during the early follicular and midluteal menstrual phases, after 4 wk of combined estradiol-norethindrone (progestin) oral contraceptive administration (OC E+P), and after 4 wk of progestin-only oral contraceptive administration (OC P). The order of the OC P and OC E+P were randomized. Baseline esophageal temperature (Tes) at 27°C was higher (P < 0.05) in the luteal phase (37.08 ± 0.21°C) and in OC P (37.60 ± 0.31°C) but not during OC E+P (37.04 ± 0.23°C) compared with the follicular phase (36.66 ± 0.21°C). Tes remained above follicular phase levels throughout passive heating and exercise during OC P, whereas Tes in the luteal phase was greater than in the follicular phase throughout exercise (P < 0.05). The Tes threshold for sweating was also greater in the luteal phase (38.02 ± 0.28°C) and OC P (38.07 ± 0.17°C) compared with the follicular phase (37.32 ± 0.11°C) and OC E+P (37.46 ± 0.18°C). Progestin administration raised the Tes threshold for sweating during OC P, but this effect was not present when estrogen was administered with progestin, suggesting that estrogen modifies progestin-related changes in temperature regulation. These data are also consistent with previous findings that estrogen lowers the thermoregulatory operating point.
progestin; thermoregulation; menstrual cycle; exercise
This article has been cited by other articles:
![]() |
G. P. Kenny, E. Leclair, R. J. Sigal, W. S. Journeay, D. Kilby, L. Nettlefold, F. D. Reardon, and O. Jay Menstrual cycle and oral contraceptive use do not modify postexercise heat loss responses J Appl Physiol, October 1, 2008; 105(4): 1156 - 1165. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. McClanahan, G. E. Aiken, and C. T. Dougherty Case Study: Influence of Rough Hair Coats and Steroid Implants on the Performance and Physiology of Steers Grazing Endophyte-Infected Tall Fescue in the Summer Professional Animal Scientist, June 1, 2008; 24(3): 269 - 276. [Abstract] [PDF] |
||||
![]() |
S. T. Sims, N. J. Rehrer, M. L. Bell, and J. D. Cotter Preexercise sodium loading aids fluid balance and endurance for women exercising in the heat J Appl Physiol, August 1, 2007; 103(2): 534 - 541. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kuwahara, Y. Inoue, M. Abe, Y. Sato, and N. Kondo Effects of menstrual cycle and physical training on heat loss responses during dynamic exercise at moderate intensity in a temperate environment Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2005; 288(5): R1347 - R1353. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Thompson and W. L. Kenney Altered neurotransmitter control of reflex vasoconstriction in aged human skin J. Physiol., July 15, 2004; 558(2): 697 - 704. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Stachenfeld and H. S. Taylor Effects of estrogen and progesterone administration on extracellular fluid J Appl Physiol, March 1, 2004; 96(3): 1011 - 1018. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Stephens, L. A. T. Bennett, K. Aoki, W. A. Kosiba, N. Charkoudian, and J. M. Johnson Sympathetic nonnoradrenergic cutaneous vasoconstriction in women is associated with reproductive hormone status Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H264 - H272. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |